Eurican DAPPi Lmulti

CAV 2, CDV, CPV, L. canicola, L.icterohaemorrhagiae, CPi, L. grippotyphosa

Product information

Trade name: Eurican DAPPi Lmulti

Active substance: CAV 2, CDV, CPV, L. canicola, L.icterohaemorrhagiae, CPi, L. grippotyphosa

Therapeutic group: Organic products

Pharmaceutical form: liofilizat şi solvent pentru suspensie injectabilă

Presentation: flacon x 1 doză

Target species: dogs

Therapeutic action: Câini Imunoprofilaxia bolii Carre, hepatitei infecţioase, parvovirozei, parainfluenţei și leptospirozei.

Waiting period: Nu este cazul.

Release mode: Cu prescripţie

Authorization data

Authorization number: 200134

Authorization status: Valida

Date of issue of the authorization: 22-09-2020

Authorization valid until: nelimitata

Manufacturer / Serial Release Company: BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE SCS, Franța

Licensee: BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE SCS, Franța

Responsible company in Romania: VETECO INTERSERVICES SRL

Remarks: Autorizat prin DCP.